2022
DOI: 10.1016/j.bios.2022.114081
|View full text |Cite
|
Sign up to set email alerts
|

A novel peptide-based electrochemical biosensor for breast cancer characterization over a poly 3-(3-aminophenyl) propionic acid matrix

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 19 publications
(7 citation statements)
references
References 39 publications
0
7
0
Order By: Relevance
“…A glassy carbon electrode (GCE) was modified with DNA-lead nanoparticles (Pb NPs) for sensitive and selective detection of the bacteria. In a study on biosensors for early detection of cancer, Alves et al (2022) developed a novel electrochemical biosensor for monitoring of breast cancer by immobilizing the biotin-C3 and biotin-H 2 peptides in the screen-printed electrodes/poly 3-(3-aminophenyl) propionic acid/ avidin system [10]. As we advanced deeper into the pandemic, we saw the need for advanced sensor technologies as a solution in the public health response to COVID-19.…”
Section: Introductionmentioning
confidence: 99%
“…A glassy carbon electrode (GCE) was modified with DNA-lead nanoparticles (Pb NPs) for sensitive and selective detection of the bacteria. In a study on biosensors for early detection of cancer, Alves et al (2022) developed a novel electrochemical biosensor for monitoring of breast cancer by immobilizing the biotin-C3 and biotin-H 2 peptides in the screen-printed electrodes/poly 3-(3-aminophenyl) propionic acid/ avidin system [10]. As we advanced deeper into the pandemic, we saw the need for advanced sensor technologies as a solution in the public health response to COVID-19.…”
Section: Introductionmentioning
confidence: 99%
“…Both synthetic peptides were shown to be capable of differentiating the serum samples of breast cancer patients from benign breast disease patients successfully. Besides, they were also tested to categorize patients with Luminal A and B breast tumours based on the expression of p53 and HER2 respectively [ 62 ].…”
Section: Discovery Of Phage-displayed Peptides For Targeting Various ...mentioning
confidence: 99%
“…43 By making use of phage display technology, da Fonseca Alves et al screened out two peptide ligands that selectively bound to luminal-type breast cancer cells, such as MCF-7. 44 The peptide ligands were immobilized at an electrode that was functionalized by a poly 3-(3-aminophenyl) propionic acid matrix, and applied to distinguish the molecular features of breast cancer patients based on the p53 status in the luminal A-subtype and the human epidermal growth factor receptor 2 (HER2) status in the luminal B-subtype by using square wave voltammetry (SWV) to monitor anionic current. By using a hydrosoluble polypeptide, octreotide, as the recognition ligand, Cong et al developed a sandwich-type electrochemical method for the detection of HeLa cells.…”
Section: Functional Peptide-based Electrochemical Biosensing Of Cance...mentioning
confidence: 99%